(Q34157966)

31 July 2017

title

Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines (English)

1 reference

31 July 2017

1 reference

Jianzhen Xu

1

0 references

author name string

Xuemei Liao

2

1 reference

31 July 2017

Na Lu

3

1 reference

31 July 2017

Wenming Liu

4

1 reference

31 July 2017

Chi-Wai Wong

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

International Journal of Cancer

31 July 2017

published in

1 reference

31 July 2017

volume

129

1 reference

31 July 2017

issue

10

1 reference

31 July 2017

page(s)

2527-2531

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

31 July 2017

cites work

1 reference

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas

21 January 2018

1 reference

Malignant glioma: genetics and biology of a grave matter.

21 January 2018

1 reference

Characterization of microRNA expression levels and their biological correlates in human cancer cell lines

21 January 2018

1 reference

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

21 January 2018

1 reference

Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation

21 January 2018

1 reference

The life of a cell: apoptosis regulation by the PI3K/PKB pathway

21 January 2018

1 reference

microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma

21 January 2018

1 reference

A computational screen for mouse signaling pathways targeted by microRNA clusters.

21 January 2018

1 reference

Computational approaches for microRNA studies: a review

21 January 2018

1 reference

Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25917

1 reference

31 July 2017

1 reference